Clinical trialNCT06385925RecruitingPhase 1, PHASE2Interventional

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

SponsorTyligand Pharmaceuticals (Suzhou) LimitedEnrollment440Malignant Neoplasm

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Cindy Li
Tyligand Bioscience (Shanghai) Limited
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Anhui Provincial Cancer Hospital
Hefei, Anhui, China
Yueyin Pan
Recruiting
Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Minglei Zhuo
Recruiting
the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Chengzhi Zhou
Recruiting
Hubei Cancer Hospital
Wuhan, Hubei, China
Bin Yang
Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China
Lin Wu
Recruiting
the First Affiliated Hospital of Nanchang University - Donghu District
Nanchang, Jiang, China
Pu LiYong Li
Recruiting
Linyi Cancer Hospital
Linyi, Shandong, China
Jianhua Shi
Recruiting
Shanghai Tenth People'S Hospital
Shanghai, Shanghai Municipality, China
Xiaojun Chen
Recruiting
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Ji Ma
Recruiting
Sir Run Run Shaw Hospital - Zhejiang University School of Med
Hangzhou, Zhejiang, China
Haizhou Lou
Recruiting
the First Affiliated Hospital - Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Jianya Zhou
Recruiting
the Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Ying Yuan
Recruiting
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
Dongqing Lv
Recruiting
Beijing Cancer Hospital, Beijing, China
Beijing, China
Lin Shen, MD
Recruiting
Shanghai Chest Hospital, Shanghai, China
Shanghai, China
Shun Lu, MD
Recruiting
Shanghai Zhongshan Hospital, Shanghai, China
Shanghai, China
Tianshu Liu, MD
Recruiting

United States

Md Anderson Cancer Center
Houston, Texas, United States
Recruiting
Next Oncology
San Antonio, Texas, United States
Recruiting
Next Virginia
Fairfax, Virginia, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 29 Apr 2024
Primary completion: 30 Oct 2026
Completion: 30 Apr 2027
Last update posted: 24 Apr 2026
Registered enrollment: 440
Registry id: NCT06385925

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.